![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 42, 29819-29825, October 15, 1999
4A Integrin Subunit in Relation to the
Differentiation State in Human Intestinal Cells*
,
,
From the Centre de Recherche en Biologie du Développement des Épitheliums et Thématique de Physiopathologie Digestive du Centre de Recherche Clinique du CUSE, Département d'anatomie et de biologie cellulaire, Faculté de médecine, Université de Sherbrooke, Sherbrooke, Québec, Canada J1H 5N4
| |
ABSTRACT |
|---|
|
|
|---|
Integrins are important mediators of cell-laminin
interactions. In the small intestinal epithelium, which consists of
spatially separated proliferative and differentiated cell populations
located, respectively, in the crypt and on the villus, laminins and
laminin-binding integrins are differentially expressed along the
crypt-villus axis. One exception to this is the integrin
Epithelial cells are characterized by special structural features
such as polarized morphology, specialized cell-cell contacts, and their
attachment to an underlying basement membrane (1). This attachment
mediates various crucial cell functions including adhesion, migration,
proliferation, differentiation, and cell survival. The biological
effects of basement membranes are largely mediated by laminins, a
growing family of structurally related molecules (2, 3), which are
expressed in a tissue-specific manner (4). Epithelia bind to laminins
via various cell membrane receptors, many of which are members of the
integrin superfamily (5-9) which can subsequently initiate
intracellular signaling cascades upon ligation to their ligand (10,
11). Some integrins, such as The integrin The intestinal epithelium, which is in constant and rapid renewal,
represents an interesting model for the study of mechanisms involved in
the determination of the cell state (25). Within its functional unit,
the crypt-villus axis, are two main distinct cell populations: the
proliferative and poorly differentiated crypt cells and the mature
enterocytes of the villus (26-28). Processes of epithelial cell growth
and functional differentiation need to be tightly regulated along the
crypt-villus axis (29, 30). Analysis of integrins and basement membrane
molecules in the human intestine has revealed particular patterns of
expression for many of these molecules, namely those involved in
laminin-cell interactions (13, 25). Of interest is the reciprocal
expression of laminin-1 and laminin-2 that has been found along the
crypt-villus axis, with laminin-1 occurring as a villus form and
laminin-2 as a crypt form, suggesting a relation between laminin form
expression and cell differentiation (31, 32). The functional relevance
of these observations was provided by the demonstration that laminin-1, but not laminin-2, can precociously induce differentiation in intestinal cells (33), suggesting that laminin-1 is critical in
triggering terminal enterocytic differentiation (33, 34). A
differential crypt-villus pattern of expression for laminin-binding integrins was also reported in the intestinal epithelium. The distribution of In this study, the expression of the Tissues--
Specimens of adult small intestine (jejunum) were
obtained from non-diseased parts of resected segments. Only specimens
obtained rapidly were used; the overall period required before freezing the tissue after surgery never exceeded 60 min. The project was in
accordance with the protocol approved by the Institutional Human
Research Review Committee for the use of human material.
Cell Culture--
The human colon carcinoma Caco-2/15 cell line,
a stable clone of the parent Caco-2 cell line (HBT 37; ATCC, Rockville,
MD) has been characterized elsewhere (42-44). These cells are unique in that upon reaching confluence they spontaneously undergo a gradual
enterocytic differentiation process, similar to that observed in the
epithelium of the intact fetal small and large intestine (42-45).
Cells between passages 53 and 70 were cultured in plastic dishes (100 mm Falcon, Becton-Dickinson Labware, Mississauga, Ontario, Canada) at
37 °C in an atmosphere of 95% air, 5% CO2, in
Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (CELLect Gold, ICN/Flow, Costa Mesa, CA), 4 mM
glutamine, and 20 mM HEPES and cultures were refed every
48 h.
The HIEC-6 cells have been generated from the normal fetal human small
intestine. These cells express a number of crypt cell markers but no
villus cell markers and are thus considered as poorly differentiated
crypt cells (41, 46). They were grown in Dulbecco's modified Eagle's
medium supplemented with 4 mM glutamine, 20 mM
HEPES, 5 ng/ml recombinant epidermal growth factor (Life Technologies,
Inc.), 0.2 IU/ml insulin (Connaught Novo Laboratories, Willowdale,
Ontario), and 5% fetal bovine serum in 100 mM plastic culture dishes (41). Cells were used between passages 5 and 15.
Primary Antibodies--
Antibodies used in this study were the
monoclonals GoH3 (Ref. 47; Pharmingen, Mississauga, Ontario) against
the extracellular domain of the Indirect Immunofluorescence--
The preparation and Optimum
Cutting Temperature embedding compound (Tissue Tek, Miles laboratories,
Elkhart, IN) embedding of tissue samples for cryosections was performed
as described previously (35). Frozen sections 3-µm thick were cut on
a Jung Frigocut 2800N cryostat (Leica Canada, St. Laurent,
Québec), spread on silane-coated glass slides, and air-dried
1 h at room temperature. Tissue sections were fixed in methanol or
ethanol (10 min, Gel Electrophoresis and Immunoblotting--
Sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on 10%
acrylamide gels and immunoblotting were performed as described
previously (33, 41, 42). Cells were washed twice in PBS and harvested
in 1 × solubilization buffer (2.3% SDS, 10% glycerol, 0.001%
bromphenol blue in 62.5 mM Tris-HCl, pH 6.8) containing 5%
Metabolic Cell Labeling and Immunoprecipitation--
Cells were
metabolically labeled using Promix [35S]methionine and
cystine (Amersham Pharmacia Biotech), 100 µCi/ml for HIEC and 200 µCi/ml for Caco-2/15 for the indicated times as described previously
(50). For certain points, cells were labeled as described above and
after the labeling period the radioactive medium was removed, cells
were washed once with complete Dulbecco's modified Eagle's medium,
and chased with 10 ml of complete Dulbecco's modified Eagle's medium
containing 10 × methionine and 10 × cystine for the
indicated times. Cells were solubilized in ice-cold lysis buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% Triton X-100, 2 µM
phenylmethylsulfonyl fluoride, 50 µg/ml leupeptin, 50 µg/ml
pepstatin, 100 µg/ml aprotinin) for 20 min on ice, then centrifuged
for 15 min at 13,000 × g. Samples were pre-cleared using 100 µl of heparin-agarose (Bio-Rad) followed by 50 µl of protein G-Sepharose (Life Technologies, Inc.) each for 1 h at 4 °C. Antibodies were added to the samples and incubated for 15 h at 4 °C followed by the addition of protein G-Sepharose for 1 h at 4 °C. Radioactive samples were analyzed under nonreduced conditions by SDS-PAGE, the gels were fixed (10% acetic acid, 45%
methanol, 45% deionized water) for 1 h and soaked for 15 min in
Amplify (Amersham Pharmacia Biotech), dried and exposed using Hyperfilm
ECL (Amersham Pharmacia Biotech).
RT-PCR--
Total RNA was isolated from cell lines or tissue
homogenates using TriZOL (Life Technologies, Inc.). The integrity of
the RNA was verified by ethidium bromide staining and the quantities were determined spectrophotometrically. Reverse transcriptase Superscript (Life Technologies, Inc.) and 0.5 µg of
oligo(dT)12-18 primer (Amersham Pharmacia Biotech) were
added to 5 µg of total RNA, as described elsewhere (51). The integrin
Cell Adhesion Assays--
The adhesion of HIEC and Caco-2/15
cells on laminin-5 was carried out in 96-well plates based on a
procedure described previously (53). Bovine serum albumin, 1%, was
used to set background binding. Purified laminin-5 was used at 10 µg/ml. The wells were coated for 1 h at 37 °C and
subsequently blocked with 0.25% bovine serum albumin for 1 h at
37 °C. Cells harvested using 10 mM EDTA, washed twice,
and 5 × 104 cells were plated per well for 30 min.
Unbound cells were removed by gently washing twice with PBS and bound
cells were fixed in 1% formaldehyde, colored with a 1%
crystal violet solution, and solubilized using 2% SDS. The plates were
read at 595 nm with a Microplate Reader (model 3550, Bio-Rad). For
inhibition studies, neutralizing antibodies were added to cells before
plating and incubated for 30 min, each at a final
concentration of 10 µg/ml.
As shown previously with the 3E1 antibody (31, 36) and confirmed
herein by using 439-9B, another antibody directed to the extracellular
domain of the molecule, the
6
4, which is thought to be
ubiquitously expressed by intestinal cells. However, in this study, a
re-evaluation of the
4 subunit expression with different
antibodies revealed that two forms of
4 exist in the human intestinal epithelium. Furthermore, we show that differentiated enterocytes express a full-length 205-kDa
4A subunit,
whereas undifferentiated crypt cells express a novel
4A
subunit that does not contain the COOH-terminal segment of the
cytoplasmic domain (
4Actd
). This new form
was not found to arise from alternative
4 mRNA
splicing. Moreover, we found that these two
4A forms can
associate into
6
4A complexes; however,
the
4Actd
integrin expressed by the
undifferentiated crypt cells is not functional for adhesion to
laminin-5. Hence, these studies identify a novel
6
4Actd
integrin expressed
in undifferentiated intestinal crypt cells that is functionally distinct.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2
1 and
3
1, are considered quite promiscuous (12) and bind various molecules including laminins, while others such as
6
1,
7
1, and
6
4 are specific for laminins (8, 13).
6
4 has a number of features
which distinguish it structurally and functionally from the other
laminin receptors of the
1 family (14-16). The
4 subunit has an unusually long cytoplasmic domain
having no homology with other integrin
subunits. Upon binding to
laminin-5,
6
4 becomes concentrated in
hemidesmosomes and is associated with intermediate filaments, making it
essential for the organization and maintenance of the epithelial
structure (17-19). This role was confirmed using transgenic mice in
which the
4 subunit had been knocked out (20, 21),
causing the loss of hemidesmosomal structures. Furthermore, mice
carrying a targeted deletion of the integrin
4
cytoplasmic domain showed defects in both cell adhesion and
proliferation (22), suggesting that
4 coordinates
hemidesmosome assembly but may be responsible for additional signals,
some of which may be essential for cell survival and cell cycle
regulation (22, 23). Indeed, upon ligation to laminin-5,
6
4 has been shown to become
phosphorylated and to cause recruitment of Shc and Grb2-mSOS, which go
on to activate Ras/MAP kinase pathways (17, 24).
2
1 was mainly restricted
to the crypt while
3
1 was found
predominantly in the villus (35, 36). More recently,
7B
1, a specific laminin receptor largely
involved in muscle development in response to laminin (37) has been
identified in the intestinal epithelium. It was found to be located at
the crypt-villus junction in the intact intestine while its expression was transiently up-regulated in differentiating enterocytes (38). In
contrast, the integrin
6
4 has been
reported to be present at the base of intestinal epithelial cells all
along the crypt-villus axis suggesting that this laminin receptor is
ubiquitously expressed by intestinal cells (31, 32, 36, 39).
4 subunit in
intestinal cells was re-evaluated on the basis of the observation that antibodies directed to the COOH-terminal segment of the cytoplasmic domain of the molecule (40) detected the
4 subunit only
in the villus cells of the intact small intestine, suggesting that two
distinct forms of
4 may exist in the intestinal
epithelium. To further investigate this, we used two well characterized
intestinal cell models which allow to some extent the recapitulation of
the crypt-villus axis in vitro: the crypt-like HIEC cells,
which are proliferative and undifferentiated (41), and the Caco-2/15
cells which have the ability to differentiate into fully functional villus-like enterocytes (42-44). Our data show that differentiated enterocytes express a full-length 205-kDa
4A subunit
while undifferentiated crypt cells express a novel
4A
subunit which does not contain the COOH-terminal segment of the
cytoplasmic domain (
4Actd
). Moreover, we
found that these two
4A variants form
6
4A complexes that are functionally
distinct with regard to adhesion activity, the
6
4Actd
receptor expressed on
undifferentiated crypt cells being inactive as opposed to the fully
functional
6
4A integrin expressed on
differentiated villus cells.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
6 integrin subunit and
3E1 (Ref. 48; Life Technologies, Inc., Burlington, Ontario) and 439-9B
(Pharmingen) both against the extracellular domain of the
4 integrin subunit; mAb13 against integrin
1 and mAb16 against integrin
5 were kind
gifts from Dr. S. K. Akiyama (Ref. 49; National Institute of
Dental Research, Bethesda, MD); P1E6 against integrin
2
(Ref. 12; Life Technologies, Inc.); and P1B5 against integrin
3 (Ref. 12; Oncogene Science, Uniondale, NY). An
anti-
4 antiserum (40) raised against the last 31 amino
acids of the cytoplasmic terminal domain of the
4
subunit (referred to hereafter as the anti-
4c antibody)
was generously provided by Dr. E. Ruoslahti (The Burnham Institute, La
Jolla, CA). Another anti-
4 antiserum (AB1922; Chemicon
International, Mississauga, Ontario) directed toward the last 20 amino
acids of the COOH-terminal domain of the
4 subunit was
also used for immunolocalization studies. Purified laminin-5 was a
generous gift from Dr. R. Burgeson (Cutaneous Biology Research Center, Charlestown, MA).
20 °C) before immunostaining, as described
elsewhere (31, 35). Primary antibodies were diluted 1/100
(anti-
4cyto and AB1922) or used at 5 µg/ml (3E1 and
439-9B). The secondary antibody was an fluorescein
isothiocyanate-conjugated goat anti-rabbit or anti-mouse IgG (Roche
Molecular Biochemicals Canada, Laval, Québec) or anti-rat IgG
(Caltag, Cedarlane Laboratories, Hornby, Ontario) used 1/25 in 2%
bovine serum albumin in PBS.1
Sections were stained with 0.01% Evan's blue in PBS, mounted in
glycerol-PBS (9:1) containing 0.1% paraphenylenediamine, and viewed
with a Reichart Polyvar 2 microscope (Leica Canada) equipped for
epifluorescence. In all cases no specific immunofluorescent staining
was observed when primary antibodies were omitted or replaced by the
corresponding non-immune serum.
-mercaptoethanol. Samples were boiled for 5 min, cleared by
centrifugation (13,000 × g, 5 min), and aliquoted for
storage at
80 °C. Separated proteins (100 µg/lane) were
transferred onto nitrocellulose (Bio-Rad, Mississauga, Ontario) and
blocked in PBS containing 10% powdered skim milk, then incubated
overnight at room temperature with primary antibodies
(anti-
4c, 1/500) diluted in the blocking solution.
Alkaline phosphatase-conjugated secondary antibodies (Bio-Rad) were
used according to the manufacturers instructions.
4 subunit was amplified using five different sets of
primers. B1/B2: B1 (5'-GAATTCGTTCTACGCTCTCC-3') and B2
(5'-GAATTCTGAGAGATGTGGGC-3') amplify a band of 369 bp which spans the
region 4182 to 4551 of
4A (14). B3/B4: B3
(5'-CCCGGGGATATCGTCGGCTAC-3') and B4 (5'-CCCGGGGCTGTCTCCATCCAC-3')
amplify a band of 83 bp (52) spanning the region of 4921 to 5004 bp of
4A; B5/B6: B5 (5'-GAATTCTTCCTAGTGGATGG-3') and B6
(5'-GAATTCCTAGTGGGACAT-3') amplify a band of 186 bp spanning the region
of 5235 to 5421 of
4A; B7/B8: B7
(5'-TCTCCGATGACACTGAGCAC-3') and B8 (5'-GTAGCCGACGATATCCCCAT-3')
amplify a band of 718 bp spanning the region of 4220-4938 of
4A; B9/B10: B9 (5'-CCCATGAAGAAAGTGCTGGT-3') and B10
(5'-TCCATCCTGGGACTCTATGG-3') amplify a band of 1202 bp spanning the
region of 3931 to 5133 of
4A. Single-stranded cDNA was amplified in PCR buffer (Amersham Pharmacia Biotech) containing 0.25 µM of both sense and antisense primers for 30 cycles
of denaturation (1 min at 94 °C), annealing (1 min at 55 °C for
B1/B2, B7/B8, and B9/B10, 65 °C for B3/B4, and 51 °C for B5/B6
and B3/B6), and extension (1 min at 72 °C) in a thermal cycler
(Perkin-Elmer DNA Thermal cycler model 480) in the presence of 250 µM dNTPs and 2.5 units of Taq (Roche Molecular
Biochemicals; obtained from Amersham Pharmacia Biotech). Conditions for
S14 amplification and sequence analysis of the
4 B3/B6
PCR products were described elsewhere (38). The
4 B9/B10
1202-bp PCR product was digested with SmaI and
SacII prior to cloning in pBluescript for sequence analysis.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
4 subunit was found to be
expressed in significant amounts at the base of all epithelial cells in
both crypt and villus (Fig.
1A). The use of another
antibody, the anti-
4c, raised against the last 31 amino
acids of the COOH-terminal of the
4 subunit, produced a
distinct pattern of expression by strongly labeling the basal surface
of villus cells but not the crypts (Fig. 1B). The
specificity of the staining pattern of the anti-
4c
antibody was confirmed with AB1922, another antibody directed against
the last 22 amino acids of the COOH-terminal of the
4
subunit (Fig. 1C). This observation suggests that at least
two immunologically distinct forms of
4 exist in the
intestinal epithelium and that they are associated with different cell
populations along the crypt-villus axis.

View larger version (99K):
[in a new window]
Fig. 1.
Different patterns of expression for the
4 subunit using specific
antibodies. Indirect immunofluorescence on normal adult human
small intestine using (A) 439-9B against the extracellular
domain and the anti-
4c (B) and AB1922
(C) both directed toward the cytoplasmic terminal domain of
the
4 subunit. All primary antibodies were detected
using fluorescein isothiocyanate-conjugated secondary antibodies.
Expression of
4 in Intestinal Epithelial
Cells--
This hypothesis was tested by analyzing the expression of
the
4 subunit in undifferentiated (HIEC) and
differentiated (Caco-2/15) cells. Western blot analysis of cell lysates
using anti-
4c (Fig. 2A) detected the
4 subunit in Caco-2/15 (lane 2) cells but not in HIEC cells (lane 1). However, RT-PCR amplification using
two different sets of primers, located in the region encoding for the
cytoplasmic domain of
4, revealed that both cell models
express the
4 transcript (Fig. 2B, lanes 2 and 4). The B1/B2 primer set spans the region which is
alternatively spliced to produce isoforms
4A,
4B, or
4C (15, 16, 40). This set of
primers amplifies a band of 369 bp which corresponds to
4A, indicating that this is the major
4
isoform in both cell lines. The primer set B3/B4 has been used
previously to identify the
4D isoform which contains a
21-bp deletion (52). The amplification of a single band of 83 bp with
this set of primers in HIEC and Caco-2/15 cells indicated that neither
cell line expresses this isoform.
|
Undifferentiated Crypt Cells Contain a Novel Form of the
4A Subunit--
The differential expression of
4 subunits between differentiated and undifferentiated
intestinal cells was further investigated by immunoprecipitation using
the 3E1 antibody, followed by Western blot detection using the
anti-
4c antibody (Fig.
3A). As expected from Western
blot analyses (previous section), the
4 subunit was only
detected in Caco-2/15 cells (lane 2) with this procedure, suggesting that the
4c epitope is absent in HIEC. To
verify this, HIEC and Caco-2/15 cells were metabolically labeled using
[35S]methionine and cystine for 6 h, then
4 was immunoprecipitated using either 3E1 or the
anti-
4c antibody. As shown in Fig. 3B, both
antibodies immunoprecipitated comparable amounts of the
4 subunit in Caco-2/15 cells, demonstrating that both
3E1 and anti-
4c epitopes are expressed in these cells
(Fig. 3B, lanes 3 and 4). In HIEC, however, the
4 subunit was detected as a 205-kDa band using 3E1
(lane 2) while the anti-
4c failed to
immunoprecipitate the protein (lane 1), indicating that HIEC
express the
4 subunit, but under a form which lacks the
4c epitope, thus distinct from the
4
subunit found in Caco-2/15 cells.
|
It has been previously reported that the
4 subunit can
undergo proteolytic cleavage in its cytoplasmic tail (40, 54, 55). The
possibility that this occurred in undifferentiated crypt cells was
investigated by pulse-chase experiments and sequential immunoprecipitation. HIEC and Caco-2/15 cells were metabolically labeled with [35S]methionine and cystine for 2 h and
chased for 0-8 h before lysis (Fig.
4A). For each sample, the
4 subunit was first immunoprecipitated using
anti-
4c antibody. Then, after two additional rounds of immunoprecipitation with anti-
4c to ensure complete
depletion of the immunoreactive
4c form in the samples,
the remaining
4 was isolated with a last
immunoprecipitation using the 3E1 antibody. This sequential
immunoprecipitation procedure showed that in Caco-2/15 cells, the
anti-
4c identified a major band at 205 kDa at all time
points corresponding to the
4 subunit (Fig. 4A,
upper left-hand panel). Subsequent immunoprecipitation of the
4c-depleted lysates using 3E1 indicated that the
majority of the
4 subunit contains the
anti-
4c epitope since very little material was recovered with 3E1 (Fig. 4A, upper right-hand panel). In contrast, in
undifferentiated HIEC cells,
4 was barely detected after
immunoprecipitation using the anti-
4c (Fig. 4A,
lower left-hand panel), even with a chase time of 0 min, the
almost complete majority of the
4 subunit being
recognized only by 3E1 (Fig. 4A, lower right-hand panel). Shortening the labeling period down to 30 min (Fig. 4B) did
not allow the detection of the
4 protein containing the
anti-
4c epitope (Fig. 4B, left-hand panel),
again the majority of the
4 subunit present being
recognized only by 3E1 (Fig. 4B, right-hand panel). This
indicates that in HIEC cells, the loss of the
4c epitope
in the
4 precursor occurs extremely rapidly.
|
The possibility that the
4 transcript may not code for
the COOH-terminal domain in undifferentiated crypt cells was verified by designing primers (B5/B6; see "Experimental Procedures") for RT-PCR that would amplify the region overlapping the nucleotides encoding the last 30 amino acids against which the
anti-
4c antibody was raised. As shown in Fig.
5, both cell lines expressed a
4A transcript that contains this sequence. To rule out
the possibility that the lack of the
4c epitope in
undifferentiated crypt cells arises from alternative splicing, the
sequence of a large section of the
4 mRNA expressed
by these cells was determined. Sequencing of the HIEC B3/B6 and B9/B10
PCR products (Fig. 5), which correspond to the last 1490 bp of the
4 mRNA encoding the carboxyl-terminal end of the
protein, did not reveal any difference with
4A (14). Hence, altogether these results indicate that undifferentiated crypt
cells express a novel form of the
4A integrin subunit
which is distinct in its COOH-terminal domain from that found in
differentiated intestinal cells.
|
The
6
4Actd
Complex in
Intestinal Crypt Cells Is Not Functional--
As shown in Fig.
4A, the co-immunoprecipitation of
6 with its
4A partner in both HIEC (with 3E1) and Caco-2/15 cells
(with the anti-
4c) indicates that
4A is
expressed in association with
6 in both cell lines. The
6
4 integrin serves as a specific receptor
for laminins, namely laminin-5 (17, 18, 53, 56-58). Adhesion of HIEC
and Caco-2/15 cells to laminin-5 was thus analyzed (Fig.
6). Adhesion of Caco-2/15 cells was
partially inhibited by the GoH3 (anti-
6) or 3E1
(anti-
4) antibodies. When both of these antibodies were
used in combination, they significantly inhibited cell adhesion,
indicating that the
6
4A complex modulates substantially Caco-2/15 cell adhesion to laminin-5 in these cells. The
mAb13 (anti-
1) antibody also significantly impaired
laminin-5 binding, suggesting that Caco-2/15 cells may use a
1 integrin in cooperation with
6
4A, but one other than
2
1 or
3
1
since the neutralizing antibodies P1E6 (anti-
2) and P1B5
(anti-
3), alone or in combination with GoH3, failed to
affect significantly Caco-2/15 cell adhesion to laminin-5. In contrast,
HIEC cell binding to laminin-5 was unaffected in the presence of GoH3
or 3E1, either alone or in combination, suggesting that
6
4Actd
is not functional.
However, HIEC cells appear to use
3
1
instead, another laminin-5 receptor, since adhesion is markedly
inhibited with P1B5 or mAb13. In combination, P1B5 and GoH3 did not
increase inhibition, supporting the interpretation that
6
4Actd
is not involved in
the binding of undifferentiated intestinal cells to laminin-5.
|
| |
DISCUSSION |
|---|
|
|
|---|
Epithelial cell proliferation, migration, and differentiation are
tightly regulated along the crypt-villus axis of the small intestine
and evidence that cell-laminin interactions play a role in their
regulation is strengthening (33, 34). As in other systems, cell-laminin
interactions are highly dynamic in the renewing intestinal epithelium,
a differential expression of both receptors and ligands having been
observed along the crypt-villus axis (13, 25). In the present study, we
have examined the function of the
6
4
integrin in the mediation of intestinal cell-laminin interactions. We
have identified two distinct forms of the
4 subunit
expressed according to the cell state in the intestinal epithelium: a
previously undescribed variant of
4A that lacks a small
terminal fragment of the cytoplasmic domain
(
4Actd
), which is expressed by crypt cells
and their normal in vitro counterpart, the HIEC cells, and
the full-length
4A subunit, which is expressed by
Caco-2/15 cells and by villus cells in the intact intestine. Our
results provide clear evidence that both variants of
4A
can associate with the
6 subunit to form a stable
6
4A complex. However, in contrast to the
6
4A present in differentiated intestinal cells, the
6
4Actd
expressed
by undifferentiated crypt cells was found to be non-functional for cell
adhesion to laminin-5.
The
4 subunit can exhibit a high degree of structural
complexity resulting from alternative splicing of its mRNA as well as proteolytic cleavage. Up to now, five distinct mRNA variants of
the human
4 integrin have been identified, each altering
the cytoplasmic domain, and designated (59)
4A, which is
the most common form (14),
4B (15),
4C
(16),
4D (52), and the newly identified
4E (60). Information about the distribution of these
variants is still limited (16, 52) and the implication of their
expression has only begun to be investigated at the functional level
(59, 61). Analysis of these variants in intestinal epithelial cells by
RT-PCR using specific primer sets revealed that both undifferentiated
and differentiated cells express mainly, if not exclusively, the
4A form. Furthermore, RT-PCR with primers designed to
amplify the 3' end of the
4A transcript encoding the
anti-
4c epitope ruled out the possibility that the
4Actd
form observed in undifferentiated
cells arises from an alternative splicing mechanism.
The expression of a
4A subunit lacking the
immunoreactive terminal portion of the cytoplasmic domain may thus
result from alteration(s) of the protein itself. Conformation changes
are unlikely since the anti-
4c antibody used in this
study is a polyclonal serum raised against a 31-amino acid stretch
(40), and lack of the anti-
4c epitope was observed under
both denaturing and nondenaturing conditions (see Figs. 2 and 3 for
comparison). However, post-translational proteolytic cleavage in the
cytoplasmic domain of the
4 subunit has been previously
reported yielding a characteristic pattern of additional bands
migrating at 165 and 125/130 kDa (40, 54, 55). These proteolytic
fragments of
4 were not detected in either HIEC or
Caco-2/15 cell extracts prepared under conditions in which proteolysis
was inhibited (Refs. 40 and 55; see "Experimental Procedures"),
indicating that such proteolysis does not occur in these cells.
Furthermore, immunofluorescent cytoplasmic staining of the
4 subunit, used as an indicator of endogenous
proteolysis in the intact tissue (40), was not observed in the
intestinal epithelium. These observations suggest that such
post-translational proteolytic cleavage of
4 does not
occur significantly in the human intestinal epithelium. Since the lack
of the anti-
4c epitope seems to be the result of
proteolysis, it is likely to take place by a distinct mechanism. First,
the actual portion of the cytoplasmic tail that appears to be deleted
in
4Actd
would be very short since no
significant difference was observed in the apparent size of
4Actd
from HIEC cells as compared with the
full-length
4A isolated from Caco-2/15 cells. Second,
its proteolysis should occur very rapidly in the biosynthetic pathway,
i.e. co-translationally, since a
4A bearing
the anti-
4Ac epitope was not detected in HIEC even after
only 30 min of labeling. Taken together, these data indicate that
undifferentiated intestinal cells constitutively express
4Actd
, a form of
4A that
lacks a short portion of the terminal cytoplasmic domain. The exact
mechanism involved in the generation of the
4Actd
form remains to be elucidated but
our observations suggest that it arises from a co-translational processing of the integrin subunit.
A second interesting observation is that even though the
4A subunit was able to associate with its
6 partner in the two cell lines studied, the
6
4Actd
complex expressed by
undifferentiated HIEC cells was found to be inactive in terms of
laminin-5 adhesion. The HIEC do bind to laminin-5 but use the
3
1 integrin, which has also been reported
to have a high affinity for this ligand (8, 62, 63). Interestingly in
these cells,
3
1 appears to function
without the cooperation of
6
4Actd
since the combination of neutralizing antibodies to
3 and
6 did not inhibit adhesion of laminin-5 significantly
more than anti-
3 alone. In a recent study, it has been
suggested that
3
1 and
6
4 can function cooperatively to mediate
adhesion (64). This was not observed in HIEC adhesion to laminin-5 even
when incubation times were extended to over 1 h (not shown), which
is consistent with the apparent inability of
6
4Actd
to bind to
laminin-5. This lack of activity was surprising in view of the fact
that tail-less
4 mutants (65, 66) can still bind to
laminin-5, albeit at a lower affinity. However, this is not without
precedent since a role for the COOH-terminal end of various other
subunit in integrin-mediated adhesion is well documented (67-70). In
this context, the relation between an apparently minor alteration in the COOH-terminal domain of the
4Actd
subunit in undifferentiated intestinal crypt cells and the lack of
activity of its
6
4 complex is of
particular interest. Indeed, the cytoplasmic domain of
4 is composed of distinct structural regions, namely two pairs of type
III fibronectin-like modules separated by a region referred to as the
connecting segment and the COOH-terminal segment. Both type III
fibronectin-like modules and the connecting segment were shown to be
important for hemidesmosome assembly including recruitment of
HD-1/plectin, BP180, and the association with the keratin cytoskeleton (17, 59, 61, 66, 71-73). However, recent evidence indicates that the
COOH-terminal segment of
4 also plays a key role in these interactions, being involved in the
4 interaction
with HD1/plectin (72), BP180 (73), and itself (72, 73). This latter
observation that the COOH-terminal end of
4 can bind
directly to a more NH2 terminally located region, which
encompasses the sequences essential for the interaction with other
hemidesmosomal components, is particularly interesting as it suggests
that the cytoplasmic domain of
4 can fold back upon
itself and thus be part of a mechanism regulating
4
interactions with HD1/plectin and PB180 (73). Further characterization
of the COOH-terminal end may reveal an additional role(s) for this
4 cytoplasmic segment. For instance, the functional
significance of the strong phosphorylation of the COOH-terminal region
of
4 reported in various epithelial cell lines (74, 75)
remains to be determined while a number of interesting features
pertaining to the cytoplasmic portion of the
4 subunit
such as the recruitment of Shc/Grb2-mSOS and subsequently activating
the Ras/MAP kinase pathways (17, 24), the ability to modulate the
cyclin-dependent kinase inhibitors p21WAF/Cip1
and p27Kip (22, 65), as well as the activation of the
phosphatidylinositol 3-OH kinase (76), have not yet been mapped.
What would be the biological relevance for undifferentiated crypt cells
to express a
6
4Actd
complex
unable to mediate adhesion to laminin? While further investigations
will be required to clearly answer this question, it is interesting to
note that the epithelial basement membrane in the crypt region is
negative for laminin-5 in the human small intestine, while it is
expressed in the villus basement membrane (39,
77),2 and therefore coincides
almost perfectly with the pattern of
4Actd+
expression. Furthermore, the expression of HD1/plectin has
also been reported to be exclusively expressed by villus intestinal
cells (77). The repression of laminin-5 and HD1/plectin expression,
coupled to the production of an inactive
6
4Actd
integrin, may thus
represent two distinct control mechanisms ensuring that type II
hemidesmosomes will not form in undifferentiated intestinal cells. It
is noteworthy that the expression of an inactive form of a molecule is
not without precedent in human intestinal crypt cells. For instance,
sucrase-isomaltase, a brush-border hydrolytic enzyme, is the subject of
a post-translational regulatory mechanism that depends on the state of
differentiation for the acquisition of its mature fully active form
(50). On the other hand, the lack of laminin binding activity of the
6
4Actd
complex in the
intestinal crypt may be of some importance, because of the presence of
laminin-2 which is distributed according to an increasing gradient from
the upper half to the bottom of the gland (31). Indeed, in addition to
laminin-1 and laminin-5, which are restricted to the villus, laminin-2
can also serve as a ligand for
6
4 (8, 23,
66). Therefore, it could be speculated that the inactivity of this
receptor in terms of laminin binding is required to allow enterocytes
to migrate upward to the villus. Finally, in light of the recent
evidence that
6
4 may exert biological activities in conditions where the interaction with its ligand does not
occur (65, 78), the
6
4Actd
complex present in crypt cells may nevertheless exert ligand
independent activities of functional relevance for undifferentiated
epithelial cells.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. R. Burgeson (Cutaneous Biology Research Center, Charlestown, MA) for providing the purified human laminin-5, Drs. S. K. Akiyama (National Institute of Dental Research, Bethesda, MD) and E. Ruoslahti (The Burnham Institute, La Jolla, CA) for their generous gift of antibodies, Drs. J. Poisson and M. Lessard of the CUSE of Sherbrooke for their cooperation in providing specimens for this study, and Dr. P. H. Vachon for comments on the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported in part by Medical Research Council of Canada Group Grant GR-15186 and the "Fonds pour la Formation des Chercheurs et l'Aide à la Recherche" (FCAR).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a studentship from the Medical Research Council of Canada.
§ Supported by FCAR.
¶ Supported by a studentship from the Université de Sherbrooke.
To whom correspondence should be addressed: Dépt.
d'anatomie et de biologie cellulaire, Faculté de médecine,
Université de Sherbrooke, Sherbrooke, Québec, Canada J1H
5N4. Tel.: 819-564-5269; Fax: 819-564-5320; E-mail:
jf.beaul@courrier.usherb.ca.
2 N. Basora and J. F. Beaulieu, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PBS, phosphate-buffered saline; PAGE, polyacrylamide gel electrophoresis; RT-PCR, reverse transcriptase-polymerase chain reaction; bp, base pair(s).
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Rodirguez-Boulan, E.,
and Nelson, W.
(1989)
Science
245,
718-725 |
| 2. | Burgeson, R. E., Chiquet, M., Deutzmann, R., Ekblom, P., Engel, J., Kleinman, H., Martin, G. R., Meneguzzi, G., Paulsson, M., Sanes, J., Timpl, R., Tryggvason, K., Yamada, Y., and Yurchenco, P. D. (1994) Matrix Biol. 14, 209-211[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Wewer, U. M., and Engvall, E. (1994) Methods Enzymol. 245, 85-104[Medline] [Order article via Infotrieve] |
| 4. | Engvall, E., Earwicker, D., Haarparanta, T., Ruoslahti, E., and Sanes, J. R. (1990) Cell Regul. 1, 731-740[Medline] [Order article via Infotrieve] |
| 5. | Ruoslahti, E. (1991) J. Clin. Invest. 87, 1-5 |
| 6. | Hynes, R. O. (1992) Cell 69, 11-25[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Sonnenberg, A. (1992) Pathol. Biol. 40, 773-778[Medline] [Order article via Infotrieve] |
| 8. | Mercurio, A. M. (1995) Trends Cell Biol. 5, 419-423[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Sheppard, D. (1996) BioEssays 18, 655-660[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Clark, E. A.,
and Brugge, J. S.
(1995)
Science
268,
233-239 |
| 11. |
Miyamoto, S.,
Teramoto, H.,
Gutkind, J. S.,
and Yamada, K. M.
(1996)
J. Cell Biol.
135,
1633-1642 |
| 12. |
Wayner, E.,
and Carter, W. G.
(1987)
J. Cell Biol.
105,
1873-1884 |
| 13. | Beaulieu, J.-F. (1997) Prog. Histochem. Cytochem. 31-4, 1-78 |
| 14. | Suzuki, S., and Naitoh, Y. (1990) EMBO J. 9, 757-763[Medline] [Order article via Infotrieve] |
| 15. | Hogervost, F., Kuikman, I., Kr, Von dem Borne, A. E. G., and Sonnenberg, A. (1990) EMBO J. 9, 765-770[Medline] [Order article via Infotrieve] |
| 16. |
Tamura, R. N.,
Cooper, H. M.,
Collo, G.,
and Quaranta, V.
(1990)
J. Cell Biol.
111,
1593-1604 |
| 17. | Mainiero, F., Pepe, A., Wary, K. K., Spinardi, L., Mohammadi, M., Schlessinger, J., and Giancotti, F. G. (1995) EMBO J. 14, 4470-4481[Medline] [Order article via Infotrieve] |
| 18. | Borradori, L., and Sonnenberg, A. (1996) Curr. Opin. Cell Biol. 8, 647-656[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Weaver, V. M.,
Peterson, O. W.,
Wang, F.,
Larabell, C. A.,
Briand, P.,
Damsky, C.,
and Bissell, M. J.
(1997)
J. Cell Biol.
137,
231-245 |
| 20. |
Dowling, J., Yu, Q-C.,
and Fuchs, E.
(1996)
J. Cell Biol.
134,
559-572 |
| 21. | Van der Neut, R., Krimpenfort, P., Calafat, J., Neissen, C. M., and Sonnenberg, A. (1996) Nat. Genet. 13, 366-369[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Murgia, C., Blaikie, P., Kim, N., Dans, M., Petrie, H. T., and Giancotti, F. G. (1998) EMBO J. 17, 3940-3951[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Giancotti, F. G. (1996) J. Cell Sci. 109, 1165-1172[Medline] [Order article via Infotrieve] |
| 24. | Mainiero, F., Murgia, C., Wary, K. K., Curatola, A. M., Pepe, A., Blumemberg, M., Westwick, J. K., Der, C. J., and Giancotti, F. G. (1997) EMBO J. 16, 2365-2375[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Beaulieu, J.-F. (1999) Front. Bioscience 4, d310-d321 |
| 26. | Leblond, C. P. (1981) Am. J. Anat. 160, 114-159[Medline] [Order article via Infotrieve] |
| 27. | Louvard, D., Kedinger, M., and Hauri, H.-P. (1992) Ann. Rev. Cell Biol. 8, 157-195[CrossRef] |
| 28. | Ménard, D., and Beaulieu, J.-F. (1994) in Membrane Physiopathology (Bkaily, G., ed) , pp. 319-341, Kluwer Academic Publisher, Norwell |
| 29. | Podolsky, D. K., and Babyatsky, M. W. (1995) in Textbook of Gastroenterology (Yamada, T., ed), 2nd Ed. , pp. 546-577, JB Lippincott, Philadelphia |
| 30. | Boyle, W. J., and Brenner, D. A. (1995) Curr. Opin. Gastroenterol. 11, 121-127 |
| 31. | Beaulieu, J.-F., and Vachon, P. H. (1994) Gastroenterology 106, 829-839[Medline] [Order article via Infotrieve] |
| 32. | Simon-Assmann, P., Duclos, B., Orian-Rousseau, V., Arnold, C., Mathelin, C., Engvall, E., and Kedinger, M. (1994) Dev. Dyn. 201, 71-85[Medline] [Order article via Infotrieve] |
| 33. |
Vachon, P. H.,
and Beaulieu, J.-F.
(1995)
Am. J. Physiol.
268,
G857-G867 |
| 34. |
De Archangelis, A.,
Neuville, P.,
Boukamel, R.,
Lefebvre, O.,
Kedinger, M.,
and Simon-Assmann, P.
(1996)
J. Cell Biol.
133,
417-430 |
| 35. |
Beaulieu, J.-F.
(1992)
J. Cell Sci.
102,
427-436 |
| 36. | Perreault, N., Vachon, P. H., and Beaulieu, J.-F. (1995) Anat. Rec. 242, 242-250[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Vachon, P. H., Xu, H., Liu, L., Loechel, F., Hayashi, Y., Arahata, K., Reed, J. C., Wewer, U. M., and Engvall, E. (1997) J. Clin. Invest. 100, 1870-1881[Medline] [Order article via Infotrieve] |
| 38. | Basora, N., Vachon, P. H., Herring-Gillam, F. E., Perreault, N., and Beaulieu, J.-F. (1997) Gastroenterology 113, 1510-1521[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Leivo, I., Tani, T., Laitinen, L., Bruns, R., Kivilaakso, E., Lehto, V. P., Burgeson, R. E., and Virtanen, I. (1996) J. Histochem. Cytochem. 44, 1267-1277[Abstract] |
| 40. |
Giancotti, F. G.,
Stepp, M. A.,
Suzuki, S.,
Engvall, E.,
and Ruoslahti, E.
(1992)
J. Cell Biol.
118,
951-959 |
| 41. | Perreault, N., and Beaulieu, J.-F. (1996) Exp. Cell Res. 224, 354-364[CrossRef][Medline] |